REGULATED PRESS RELEASE published on 10/13/2025 at 07:00, 6 months 25 days ago BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie BIOPHYTIS et un consortium d'investisseurs lancent le premier essai clinique de Phase 3 dans la sarcopénie, avec une coentreprise à Hong Kong et un investissement de 20 M$. Opérations cliniques prévues début 2026 Biophytis Investisseurs Essai Clinique Coentreprise Sarcopénie
PRESS RELEASE published on 10/13/2025 at 06:59, 6 months 25 days ago BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie Biophytis et un consortium d'investisseurs, dont Ronghui Renhe Life Technology, s'unissent pour lancer l'essai clinique de Phase 3 en sarcopénie, avec une coentreprise à Hong-Kong Biophytis Essai Clinique Coentreprise Sarcopénie Consortium D'investisseurs
BRIEF published on 09/30/2025 at 07:05, 7 months 7 days ago Biophytis to Engage in Key Events in Q4 2025 Biophytis Partnerships Longevity Sarcopenia Biotechnology Events
BRIEF published on 09/30/2025 at 07:05, 7 months 7 days ago Biophytis Renforce Sa Présence sur la Scène Internationale au 4ème Trimestre 2025 Biophytis Partenariats Sarcopénie Biotechnologies Événements Internationaux
REGULATED PRESS RELEASE published on 09/30/2025 at 07:00, 7 months 7 days ago Biophytis to Participate in Four Key Events in Q4 2025 Biophytis to participate in four major international events in Q4 2025, showcasing its progress in transformative therapies impacting longevity and seeking new partnerships Biophytis Partnerships Longevity International Events Transformative Therapies
REGULATED PRESS RELEASE published on 09/30/2025 at 07:00, 7 months 7 days ago Biophytis annonce sa participation à quatre événements clés au cours du 4ème trimestre 2025 Biophytis annonce sa participation à quatre événements clés internationaux au 4ème trimestre 2025 pour présenter ses avancées dans la santé et renforcer ses partenariats Biophytis Développement Participation Événements Clés 4ème Trimestre 2025
BRIEF published on 09/15/2025 at 07:05, 7 months 22 days ago Biophytis renforce sa présence au Brésil avec un financement public et des partenariats clés Biophytis Brésil Essai Clinique Obésité Financement Public
BRIEF published on 09/15/2025 at 07:05, 7 months 22 days ago Biophytis Secures Funding for Obesity Trial in Brazil Biophytis Brazil Obesity Trial EMBRAPII Clinical Partnerships
REGULATED PRESS RELEASE published on 09/15/2025 at 07:00, 7 months 22 days ago Biophytis Secures public funding in Brazil for Obesity Phase 2 Trial and Signs Agreements with Leading local Clinical Partners Biophytis secures public funding in Brazil for Obesity Phase 2 trial and signs agreements with leading local clinical partners, strengthening its OBA Phase 2 program and obtaining non-dilutive funding support through EMBRAPII Biophytis Public Funding EMBRAPII Obesity Phase 2 Trial Clinical Partners
REGULATED PRESS RELEASE published on 09/15/2025 at 07:00, 7 months 22 days ago Biophytis obtient un financement public au Brésil pour l’essai de Phase 2 dans l’obésité et signe des accords avec des centres cliniques locaux de premier plan Biophytis obtient un financement public et signe des accords pour l'essai de Phase 2 dans l'obésité au Brésil, renforçant ainsi son programme et sa valeur pour les investisseurs Biophytis Brésil Phase 2 Obésité Financement Public
Published on 05/07/2026 at 14:35, 21 minutes ago Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 26 minutes ago Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 14:30, 26 minutes ago Loar Holdings Inc. Reports Q1 2026 Record Results and Upward Revision to 2026 Outlook
Published on 05/07/2026 at 14:00, 56 minutes ago Adcore to Publish First Quarter 2026 Results on May 14, 2026
Published on 05/07/2026 at 14:00, 56 minutes ago Metallic Minerals Announces Option Agreement with Argyle Resources on McKay Hill Property, Yukon
Published on 05/07/2026 at 14:30, 26 minutes ago More charging power than the grid connection can provide: Battery-buffered microgrid unlocks new potential for fast charging
Published on 05/07/2026 at 14:05, 50 minutes ago Addepar Introduces ADX, Enabling Data Activation and AI at Scale
Published on 05/07/2026 at 14:02, 53 minutes ago Genel Energy PLC: Results of Annual General Meeting 7 May 2026
Published on 05/07/2026 at 07:43, 7 hours 12 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 20 hours 55 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 20 hours 55 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 20 hours 56 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026